Evaluating the Content Validity, Clarity, and Relevance of Two Patient-Reported Outcomes for Use With Adults With EGFR-Mutated NSCLC

INTRODUCTION: NSCLCs account for most lung cancers; approximately 30% involve a mutation in the EGFR gene. This study sought to identify one or more patient-reported outcome (PRO) measures relevant for use in clinical trials to assess symptoms and health-related quality of life in this population. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Horn, Marcia K., Liu, Kevin, Mathias, Susan D., Colwell, Hilary H., Li, Tracy, Mahadevia, Parthiv, Pierson, Renee F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474204/
https://www.ncbi.nlm.nih.gov/pubmed/34590043
http://dx.doi.org/10.1016/j.jtocrr.2021.100198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474204/
https://www.ncbi.nlm.nih.gov/pubmed/34590043
http://dx.doi.org/10.1016/j.jtocrr.2021.100198

Ejemplares similares